CorMedix (CRMD) Tops Q3 EPS by 7c

CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.81 million .

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Kite Realty sells City Center in White Plains for $50 million
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance